Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
SkyCell
company
About
SkyCell developed the next generation of temperature controlled logistics containers for the pharmaceutical industry.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- Fr62M
- Industries
- Logistics,Pharmaceutical,Supply Chain Management
- Founded date
- Jan 1, 2013
- Number Of Employee
- 11 - 50
- Operating Status
- Active
SkyCell is a Swiss-based, award-winning provider of temperature-controlled container solutions with a special focus on serving global pharma companies and sustainability. They are driven by their mission to supply the safest pharma containers worldwide. This is achieves through their unique combination of hardware, software and service, which enables us to master logistical challenges and eliminate temperature excursion.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
Fr62M
SkyCell has raised a total of
Fr62M
in funding over 2 rounds. Their latest funding was raised on
Apr 28, 2020 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 28, 2020 | Series Unknown | Fr62M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
SkyCell is funded by 1 investors.
Swiss Entrepreneurs Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Swiss Entrepreneurs Fund
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
